As many as half the drug injectors in Britain may be infected with hepatitis C, a virus which can lead to cirrhosis and fatal liver cancer. Treatment is successful in only a minority of cases. As with HIV, the body’s antibodies do not neutralise the virus and those infected with it can continue to transfer it to others via shared injecting equipment, unsafe sex or from mother to baby. Extra funds are urgently needed to help services cope with prevention and treatment.